Royalty Pharma plc - Class A
RPRX
historical activity
| Quarter | Shares | +/- Shares | Change % | Value($) | % of Total value | Avg Report Price($) |
|---|---|---|---|---|---|---|
| Q4 2024 | 12.2M | +113.9K | ↑0.94% | 311.4M | 1% | 25.51 |
| Q3 2024 | 12.1M | +124.0K | ↑1.04% | 342.1M | 1.24% | 28.29 |
| Q2 2024 | 12.0M | +484.5K | ↑4.22% | 315.7M | 1.21% | 26.37 |
| Q1 2024 | 11.5M | +1.4M | ↑13.86% | 348.8M | 1.29% | 30.37 |
| Q4 2023 | 10.1M | +623.2K | ↑6.58% | 283.4M | 1.03% | 28.09 |
| Q3 2023 | 9.5M | -386.7K | ↓3.93% | 256.9M | 1.04% | 27.14 |
| Q2 2023 | 9.9M | -1.4M | ↓12.08% | 302.8M | 1.23% | 30.74 |
| Q1 2023 | 11.2M | +1.2M | ↑11.95% | 403.7M | 1.89% | 36.03 |
| Q4 2022 | 10.0M | -873.1K | ↓8.02% | 395.5M | 1.98% | 39.52 |
| Q3 2022 | 10.9M | -1.5M | ↓12.04% | 437.2M | 2.01% | 40.18 |
| Q2 2022 | 12.4M | +1.6M | ↑14.92% | 520.1M | 2.37% | 42.04 |
| Q1 2022 | 10.8M | = | = | 419.4M | 1.69% | 38.96 |